Early Experience of Physician-Modified Endografts for Total Aortic Arch Repair
PMEG for total endovascular arch repair presents a possible alternative to open surgical repair or existing company manufactured arch devices in selected patients. Perioperative stroke and mortality risk and rate of reintervention with total endovascular arch repair using a physician-modified device remain significant.
Authors
- Agustín Sibona (ORCID: https://orcid.org/0000-0001-9174-7916)
- Kathryn DiLosa (ORCID: https://orcid.org/0000-0002-1984-5711)
- Eugene Golts (ORCID: https://orcid.org/0000-0002-6289-5773)
- Ann C. Gaffey
- Ian C. Glenn (ORCID: https://orcid.org/0000-0002-9718-6504)
- Andrew Barleben (ORCID: https://orcid.org/0000-0003-1586-084X)
- Elsie Ross (ORCID: https://orcid.org/0000-0002-9366-0109)
- Rohini J. Patel (ORCID: https://orcid.org/0000-0002-9812-6992)
- Mahmoud B. Malas
Institutions
- University of California San Diego (US)
- University of California San Diego Medical Center (US)
- University of California Davis Medical Center (US)
Publication Details
- Journal
- Annals of Vascular Surgery
- Published
- 2025-10-17
- DOI
- https://doi.org/10.1016/j.avsg.2025.10.004
- Primary Topic
- Aortic Disease and Treatment Approaches
- Type
- article
- Field-Weighted Citation Impact
- 0.00